Results 31 – 40 of 151 for vaccine Covid (0.04 seconds)

AstraZeneca and IDT Biologika sign letter of intent to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity

AstraZeneca and IDT Biologika sign letter of intent to increase COVID-19 vaccine manufacturing in Europe and secure long-term supply capacity

Statement on COVID-19 vaccine supply at Anagni plant in Italy

Statement on COVID-19 vaccine supply at Anagni plant in Italy

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

AZD1222 Oxford Phase III trials interim analysis results published in The Lancet

Interim analysis showed vaccine is effective at preventing COVID-19, with no severe cases and no hospitalisations more than 21 days after first ...

AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK

AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK

AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe

AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe

AstraZeneca’s scientific and social commitment for COVID-19 vaccine

AstraZeneca’s scientific and social commitment for COVID-19 vaccine

COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials

COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials

AstraZeneca to deliver six million COVID-19 vaccine doses in Thailand

AstraZeneca to deliver six million COVID-19 vaccine doses in Thailand

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next